rss
Br J Ophthalmol 84:983-986 doi:10.1136/bjo.84.9.983
  • Original Article
    • Clinical science

Recombinant tissue plasminogen activator following paediatric cataract surgery

Table 1

Details of patients

Visual acuity
Postinjection
Patient Age Sex IOL inserted Days to injection Complications Preinjection 1/52  3/12
1 7 years F Chiron Vision-IO LAB 7 days, dose 25 μg Mild residual fibrin 6/60 6/12  6/6
2 4 years F Pharmacia-Heparin  coated 4 days, dose 10 μg Nil 3/60 6/18  6/18
3 5 years F Chiron Vision IO LAB 14 days, dose 25 μg Residual posterior  synechiae 2/60 6/12  6/9
4 6 years F Chiron Vision IO LAB 4 days, dose 25 μg Residual posterior  synechiae 6/60 6/24  6/18

This Article

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.